In a different study, involving a cohort of 143 patients with SSc at different stages (early, non-fibrotic, limited cutaneous SSc, or diffuse cutaneous SSc), it was demonstrated that higher levels of CXCL10 could predict a shorter time until SSc progression. This evidence concerns the gene CXCL10 and systemic sclerosis.